NM_001387283.1:c.4864+10G>C
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001387283.1(SMARCA4):c.4864+10G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000027 ( 0 hom. )
Consequence
SMARCA4
NM_001387283.1 intron
NM_001387283.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0710
Publications
1 publications found
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-11059895-G-C is Benign according to our data. Variant chr19-11059895-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 733793.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.4864+10G>C | intron_variant | Intron 34 of 35 | NM_001387283.1 | ENSP00000495368.1 | ||||
| SMARCA4 | ENST00000344626.10 | c.4768+10G>C | intron_variant | Intron 33 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
| SMARCA4 | ENST00000643549.1 | c.4774+10G>C | intron_variant | Intron 33 of 34 | ENSP00000493975.1 | |||||
| SMARCA4 | ENST00000541122.6 | c.4678+10G>C | intron_variant | Intron 33 of 34 | 5 | ENSP00000445036.2 | ||||
| SMARCA4 | ENST00000643296.1 | c.4678+10G>C | intron_variant | Intron 32 of 33 | ENSP00000496635.1 | |||||
| SMARCA4 | ENST00000644737.1 | c.4678+10G>C | intron_variant | Intron 32 of 33 | ENSP00000495548.1 | |||||
| SMARCA4 | ENST00000589677.5 | c.4675+10G>C | intron_variant | Intron 33 of 34 | 5 | ENSP00000464778.1 | ||||
| SMARCA4 | ENST00000643995.1 | c.4189+10G>C | intron_variant | Intron 30 of 31 | ENSP00000496004.1 | |||||
| SMARCA4 | ENST00000644963.1 | c.3418+10G>C | intron_variant | Intron 26 of 27 | ENSP00000495599.1 | |||||
| SMARCA4 | ENST00000644065.1 | c.3400+10G>C | intron_variant | Intron 25 of 26 | ENSP00000493615.1 | |||||
| SMARCA4 | ENST00000642350.1 | c.3262+10G>C | intron_variant | Intron 25 of 26 | ENSP00000495355.1 | |||||
| SMARCA4 | ENST00000643857.1 | c.3028+10G>C | intron_variant | Intron 23 of 24 | ENSP00000494159.1 | |||||
| SMARCA4 | ENST00000538456.4 | c.832+10G>C | intron_variant | Intron 6 of 7 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152148Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
152148
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00000404 AC: 1AN: 247510 AF XY: 0.00000745 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
247510
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460930Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 726782 show subpopulations
GnomAD4 exome
AF:
AC:
4
AN:
1460930
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
726782
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33474
American (AMR)
AF:
AC:
0
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26124
East Asian (EAS)
AF:
AC:
2
AN:
39692
South Asian (SAS)
AF:
AC:
1
AN:
86214
European-Finnish (FIN)
AF:
AC:
0
AN:
52770
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1111804
Other (OTH)
AF:
AC:
0
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152266Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
152266
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41572
American (AMR)
AF:
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5178
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67998
Other (OTH)
AF:
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Benign:1
Jun 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.